Northern Trust’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.27M | Sell |
|
|||||
|
2025
Q2 | $3.98M | Sell |
|
|||||
|
2025
Q1 | $4.47M | Buy |
|
|||||
|
2024
Q4 | $3.1M | Sell |
|
|||||
|
2024
Q3 | $4.39M | Buy |
|
|||||
|
2024
Q2 | $3.92M | Buy |
|
|||||
|
2024
Q1 | $3.77M | Sell |
|
|||||
|
2023
Q4 | $4M | Buy |
|
|||||
|
2023
Q3 | $2.65M | Buy |
|
|||||
|
2023
Q2 | $2.35M | Buy |
|
|||||
|
2023
Q1 | $1.86M | Sell |
|
|||||
|
2022
Q4 | $1.64M | Sell |
|
|||||
|
2022
Q3 | $3.55M | Buy |
|
|||||
|
2022
Q2 | $2.4M | Sell |
|
|||||
|
2022
Q1 | $3.65M | Sell |
|
|||||
|
2021
Q4 | $3.37M | Buy |
|
|||||
|
2021
Q3 | $4.08M | Sell |
|
|||||
|
2021
Q2 | $5.79M | Buy |
|
|||||
|
2021
Q1 | $5.88M | Sell |
|
|||||
|
2020
Q4 | $4.35M | Sell |
|
|||||
|
2020
Q3 | $3.01M | Sell |
|
|||||
|
2020
Q2 | $2.93M | Buy |
|
|||||
|
2020
Q1 | $1.45M | Buy |
|
|||||
|
2019
Q4 | $3.31M | Buy |
|
|||||
|
2019
Q3 | $2.07M | Buy |
|
|||||
|
2019
Q2 | $1.64M | Buy |
|
|||||
|
2019
Q1 | $1.17M | Buy |
|
|||||
|
2018
Q4 | $805K | Buy |
|
|||||
|
2018
Q3 | $678K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $9K | Hold |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $82K | Sell |
|
|||||
|
2015
Q4 | $461K | Hold |
|
|||||
|
2015
Q3 | $454K | Buy |
|
|||||
|
2015
Q2 | $209K | Buy |
|